{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:25Z","timestamp":1792783285997,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Princess Nourah bint Abdulrahman University","award":["PNURSP2026R814"],"award-info":[{"award-number":["PNURSP2026R814"]}],"id":[{"id":"https:\/\/ror.org\/05b0cyh02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Princess Nourah bint Abdulrahman University","award":["PNURSP2026R814"],"award-info":[{"award-number":["PNURSP2026R814"]}],"id":[{"id":"https:\/\/ror.org\/05b0cyh02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Princess Nourah bint Abdulrahman University","award":["PNURSP2026R814"],"award-info":[{"award-number":["PNURSP2026R814"]}],"id":[{"id":"https:\/\/ror.org\/05b0cyh02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Princess Nourah bint Abdulrahman University","award":["PNURSP2026R814"],"award-info":[{"award-number":["PNURSP2026R814"]}],"id":[{"id":"https:\/\/ror.org\/05b0cyh02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Princess Nourah bint Abdulrahman University","award":["PNURSP2026R814"],"award-info":[{"award-number":["PNURSP2026R814"]}],"id":[{"id":"https:\/\/ror.org\/05b0cyh02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Princess Nourah bint Abdulrahman University","award":["PNURSP2026R814"],"award-info":[{"award-number":["PNURSP2026R814"]}],"id":[{"id":"https:\/\/ror.org\/05b0cyh02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Princess Nourah bint Abdulrahman University","award":["PNURSP2026R814"],"award-info":[{"award-number":["PNURSP2026R814"]}],"id":[{"id":"https:\/\/ror.org\/05b0cyh02","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09848-1","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:00:05Z","timestamp":1790305205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CSF neuroinflammatory biomarkers are associated with amyloid-\u03b242\/40, tau pathology, and cognitive impairment across the Alzheimer\u2019s disease spectrum"],"prefix":"10.1007","volume":"74","author":[{"given":"Mubarak","family":"Alruwaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej Ahmed","family":"Turkistani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sireen Abdul Rahim","family":"Shilbayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahlia Soleman A.","family":"Mirdad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Fareed","family":"Almulhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud","family":"Alnaaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhannad","family":"Almubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"1","key":"9848_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","volume":"17","author":"AA Abdulkhaliq","year":"2026","unstructured":"Abdulkhaliq AA, Kim B, Almoghrabi YM, Khan J, Ajoolabady A, Ren J, et al. Amyloid-\u03b2 and Tau in Alzheimer\u2019s disease: pathogenesis, mechanisms, and interplay. Cell Death Dis. 2026;17(1):21. https:\/\/doi.org\/10.1038\/s41419-025-08186-8.","journal-title":"Cell Death Dis"},{"key":"9848_CR2","doi-asserted-by":"crossref","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomed. 2019:5541\u201354.","DOI":"10.2147\/IJN.S200490"},{"issue":"1","key":"9848_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A. The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states. Mol Brain. 2024;17(1):44. https:\/\/doi.org\/10.1186\/s13041-024-01118-1.","journal-title":"Mol Brain"},{"issue":"6","key":"9848_CR4","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41380-025-02939-9","volume":"30","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H. Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry. 2025;30(6):2783\u201398. https:\/\/doi.org\/10.1038\/s41380-025-02939-9.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"9848_CR5","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41380-025-02939-9","volume":"30","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H. Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry. 2025;30(6):2783\u201398.","journal-title":"Mol Psychiatry"},{"key":"9848_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ibneur.2026.08.008","volume":"21","author":"A Azargoonjahromi","year":"2026","unstructured":"Azargoonjahromi A, Abutalebian F, Nasiri H. NF-\u03baB across the Alzheimer disease spectrum: Context-dependent protective and pathogenic roles. IBRO Neurosci Rep. 2026;21:518\u201341. https:\/\/doi.org\/10.1016\/j.ibneur.2026.08.008.","journal-title":"IBRO Neurosci Rep"},{"issue":"11","key":"9848_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2174\/1567205014666170203141717","volume":"14","author":"F Regen","year":"2017","unstructured":"Regen F, Hellmann-Regen J, Costantini E, Reale M. Neuroinflammation and Alzheimer\u2019s disease: implications for microglial activation. Curr Alzheimer Res. 2017;14(11):1140\u20138.","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"9848_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","volume":"16","author":"M Fakhoury","year":"2018","unstructured":"Fakhoury M. Microglia and astrocytes in Alzheimer\u2019s disease: implications for therapy. Curr Neuropharmacol. 2018;16(5):508\u201318.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"9848_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3233\/JAD-230199","volume":"95","author":"Y Wu","year":"2023","unstructured":"Wu Y, Eisel UL. Microglia-astrocyte communication in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2023;95(3):785\u2013803.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"9848_CR10","doi-asserted-by":"publisher","first-page":"1708775","DOI":"10.3389\/fncel.2025.1708775","volume":"19","author":"K Hashimoto","year":"2025","unstructured":"Hashimoto K, Gotoh M, Ikeshima-Kataoka H. Astrocytic and microglial cell functions in neuroinflammatory diseases and their animal models. Front Cell Neurosci. 2025;19:1708775. https:\/\/doi.org\/10.3389\/fncel.2025.1708775.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"9848_CR11","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, et al. Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain. 2021;144(11):3505\u201316. https:\/\/doi.org\/10.1093\/brain\/awab223.","journal-title":"Brain"},{"issue":"12","key":"9848_CR12","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/brain\/awae211","volume":"147","author":"DE Peretti","year":"2024","unstructured":"Peretti DE, Boccalini C, Ribaldi F, Scheffler M, Marizzoni M, Ashton NJ, et al. Association of glial fibrillary acid protein, Alzheimer\u2019s disease pathology and cognitive decline. Brain. 2024;147(12):4094\u2013104. https:\/\/doi.org\/10.1093\/brain\/awae211.","journal-title":"Brain"},{"key":"9848_CR13","doi-asserted-by":"publisher","first-page":"9340610","DOI":"10.1155\/2017\/9340610","volume":"2017","author":"X Zhang","year":"2017","unstructured":"Zhang X, Yan F, Cui J, Wu Y, Luan H, Yin M, et al. Triggering Receptor Expressed on Myeloid Cells 2 Overexpression Inhibits Proinflammatory Cytokines in Lipopolysaccharide-Stimulated Microglia. Mediators Inflamm. 2017;2017:9340610. https:\/\/doi.org\/10.1155\/2017\/9340610.","journal-title":"Mediators Inflamm"},{"issue":"7","key":"9848_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/14728222.2018.1486823","volume":"22","author":"Y Deming","year":"2018","unstructured":"Deming Y, Li Z, Benitez BA, Cruchaga C. Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease? Expert Opin Ther Targets. 2018;22(7):587\u201398. https:\/\/doi.org\/10.1080\/14728222.2018.1486823.","journal-title":"Expert Opin Ther Targets"},{"key":"9848_CR15","doi-asserted-by":"publisher","first-page":"115218","DOI":"10.1016\/j.biopha.2023.115218","volume":"165","author":"Y Li","year":"2023","unstructured":"Li Y, Xu H, Wang H, Yang K, Luan J, Wang S. TREM2: Potential therapeutic targeting of microglia for Alzheimer\u2019s disease. Biomed Pharmacother. 2023;165:115218. https:\/\/doi.org\/10.1016\/j.biopha.2023.115218.","journal-title":"Biomed Pharmacother"},{"key":"9848_CR16","doi-asserted-by":"publisher","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med. 2019;11(507). https:\/\/doi.org\/10.1126\/scitranslmed.aav6221.","DOI":"10.1126\/scitranslmed.aav6221"},{"key":"9848_CR17","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3389\/fimmu.2018.01302","volume":"9","author":"Y-y Luan","year":"2018","unstructured":"Luan Y-y. Yao Y-m. The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Front Immunol. 2018;9:1302.","journal-title":"Front Immunol"},{"issue":"6","key":"9848_CR18","doi-asserted-by":"publisher","first-page":"e13164","DOI":"10.1111\/bpa.13164","volume":"33","author":"Y Pastorello","year":"2023","unstructured":"Pastorello Y, Carare RO, Banescu C, Potempa L, Di Napoli M, Slevin M. Monomeric C-reactive protein: a novel biomarker predicting neurodegenerative disease and vascular dysfunction. Brain Pathol. 2023;33(6):e13164.","journal-title":"Brain Pathol"},{"issue":"1","key":"9848_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-018-0353-3","volume":"10","author":"F Brosseron","year":"2018","unstructured":"Brosseron F, Trasch\u00fctz A, Widmann CN, Kummer MP, Tacik P, Santarelli F, et al. Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer\u2019s disease. Alzheimers Res Ther. 2018;10(1):25. https:\/\/doi.org\/10.1186\/s13195-018-0353-3.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"9848_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflamm. 2008;5(1):45.","journal-title":"J Neuroinflamm"},{"key":"9848_CR21","doi-asserted-by":"publisher","first-page":"638922","DOI":"10.3389\/fnagi.2021.638922","volume":"13","author":"JA Pillai","year":"2021","unstructured":"Pillai JA, Bebek G, Khrestian M, Bena J, Bergmann CC, Bush WS, et al. TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer\u2019s Disease. Front Aging Neurosci. 2021;13:638922. https:\/\/doi.org\/10.3389\/fnagi.2021.638922.","journal-title":"Front Aging Neurosci"},{"key":"9848_CR22","doi-asserted-by":"publisher","first-page":"254248232513624","DOI":"10.1177\/25424823251362483","volume":"9","author":"A Azargoonjahromi","year":"2025","unstructured":"Azargoonjahromi A, Nasiri H. Higher p-Cresol sulfate and tumor necrosis factor (TNF)-\u03b1 levels are associated with cognitive improvement through increased TNF receptor 2 in individuals with mild cognitive impairment: A cross-sectional mediation analysis. J Alzheimers Dis Rep. 2025;9:25424823251362483. https:\/\/doi.org\/10.1177\/25424823251362483.","journal-title":"J Alzheimers Dis Rep"},{"key":"9848_CR23","doi-asserted-by":"publisher","unstructured":"Steeland S, Gorl\u00e9 N, Vandendriessche C, Balusu S, Brkic M, Van Cauwenberghe C, et al. Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer\u2019s disease. EMBO Mol Med. 2018;10(4). https:\/\/doi.org\/10.15252\/emmm.201708300.","DOI":"10.15252\/emmm.201708300"},{"key":"9848_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbi.2013.01.083","volume":"30","author":"Z Chen","year":"2013","unstructured":"Chen Z, Palmer TD. Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis. Brain Behav Immun. 2013;30:45\u201353.","journal-title":"Brain Behav Immun"},{"key":"9848_CR25","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","volume":"9","author":"S Yang","year":"2018","unstructured":"Yang S, Wang J, Brand DD, Zheng SG. Role of TNF\u2013TNF receptor 2 signal in regulatory T cells and its therapeutic implications. Front Immunol. 2018;9:784.","journal-title":"Front Immunol"},{"issue":"4","key":"9848_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10571-015-0232-4","volume":"36","author":"M Qian","year":"2016","unstructured":"Qian M, Shen X, Wang H. The distinct role of ADAM17 in APP proteolysis and microglial activation related to Alzheimer\u2019s disease. Cell Mol Neurobiol. 2016;36(4):471\u201382.","journal-title":"Cell Mol Neurobiol"},{"key":"9848_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1750-1326-6-69","volume":"6","author":"H Jiang","year":"2011","unstructured":"Jiang H, Hampel H, Prvulovic D, Wallin A, Blennow K, Li R, et al. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease. Mol Neurodegener. 2011;6:69. https:\/\/doi.org\/10.1186\/1750-1326-6-69.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"9848_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3181cb3e25.","journal-title":"Neurology"},{"issue":"7","key":"9848_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344. https:\/\/doi.org\/10.1212\/wnl.34.7.939.","journal-title":"Neurology"},{"issue":"1","key":"9848_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin A-C, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu C-C. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegeneration. 2022;17(1):72. https:\/\/doi.org\/10.1186\/s13024-022-00574-4.","journal-title":"Mol Neurodegeneration"},{"issue":"1","key":"9848_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13195-020-00740-0","volume":"13","author":"A Gharbi-Meliani","year":"2021","unstructured":"Gharbi-Meliani A, Dugravot A, Sabia S, Regy M, Fayosse A, Schnitzler A, et al. The association of APOE \u03b54 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alzheimers Res Ther. 2021;13(1):5. https:\/\/doi.org\/10.1186\/s13195-020-00740-0.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"9848_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S1041610296002529","volume":"8","author":"E Magni","year":"1996","unstructured":"Magni E, Binetti G, Padovani A, Cappa SF, Bianchetti A, Trabucchi M. The Mini-Mental State Examination in Alzheimer\u2019s disease and multi-infarct dementia. Int Psychogeriatr. 1996;8(1):127\u201334.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"9848_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S1041610296002578","volume":"8","author":"RC Mohs","year":"1996","unstructured":"Mohs RC. The Alzheimer\u2019s disease assessment scale. Int Psychogeriatr. 1996;8(2):195\u2013203.","journal-title":"Int Psychogeriatr"},{"key":"9848_CR34","doi-asserted-by":"publisher","unstructured":"Tzeng R-C, Yang Y-W, Hsu K-C, Chang H-T, Chiu P-Y. Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages. Front Aging Neurosci. 2022;14. https:\/\/doi.org\/10.3389\/fnagi.2022.1021792.","DOI":"10.3389\/fnagi.2022.1021792"},{"issue":"5","key":"9848_CR35","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awae035","volume":"147","author":"P S\u00e1nchez-Juan","year":"2024","unstructured":"S\u00e1nchez-Juan P, Valeriano-Lorenzo E, Ruiz-Gonz\u00e1lez A, Pastor AB, Rodrigo Lara H, L\u00f3pez-Gonz\u00e1lez F, et al. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Brain. 2024;147(5):1667\u201379. https:\/\/doi.org\/10.1093\/brain\/awae035.","journal-title":"Brain"},{"key":"9848_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.47134\/phms.v3i1.519","volume":"3","author":"K Sumadewi","year":"2025","unstructured":"Sumadewi K. The Role of GFAP as a Marker of Astrocyte Activation in the Pathogenesis of Alzheimer\u2019s Dementia. Literature Rev Health Med Sci. 2025;3:13. https:\/\/doi.org\/10.47134\/phms.v3i1.519.","journal-title":"Literature Rev Health Med Sci"},{"key":"9848_CR37","doi-asserted-by":"publisher","first-page":"1739875","DOI":"10.3389\/fimmu.2026.1739875","volume":"17","author":"T Wang","year":"2026","unstructured":"Wang T, Liu X, Wang X, Hua F, Yan L. TREM2 and microglial immunity in Alzheimer\u2019s disease: mechanisms, genetics, and therapeutic opportunities. Front Immunol. 2026;17:1739875. https:\/\/doi.org\/10.3389\/fimmu.2026.1739875.","journal-title":"Front Immunol"},{"key":"9848_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-026-03505-7","author":"AA Abdulkhaliq","year":"2026","unstructured":"Abdulkhaliq AA, Alasiri G, Kim B, Khan J, Ajoolabady A, Yousof SM, et al. TREM2 in neurodegeneration and diseases. Mol Psychiatry. 2026. https:\/\/doi.org\/10.1038\/s41380-026-03505-7.","journal-title":"Mol Psychiatry"},{"key":"9848_CR39","unstructured":"Singh B, Goyal A, Patel BC. C-reactive protein: clinical relevance and interpretation. StatPearls [Internet]. StatPearls Publishing. 2025."},{"issue":"1","key":"9848_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13287-020-01740-5","volume":"11","author":"G Beldi","year":"2020","unstructured":"Beldi G, Khosravi M, Abdelgawad ME, Salomon BL, Uzan G, Haouas H, et al. TNF\u03b1\/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function. Stem Cell Res Ther. 2020;11(1):281. https:\/\/doi.org\/10.1186\/s13287-020-01740-5.","journal-title":"Stem Cell Res Ther"},{"key":"9848_CR41","doi-asserted-by":"publisher","unstructured":"Plantone D, Pardini M, Righi D, Manco C, Colombo BM, De Stefano N. The role of TNF-\u03b1 in Alzheimer\u2019s disease: a narrative review. Cells. 2023;13(1). https:\/\/doi.org\/10.3390\/cells13010054.","DOI":"10.3390\/cells13010054"},{"issue":"4","key":"9848_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10571-015-0232-4","volume":"36","author":"M Qian","year":"2016","unstructured":"Qian M, Shen X, Wang H. The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer\u2019s Disease. Cell Mol Neurobiol. 2016;36(4):471\u201382. https:\/\/doi.org\/10.1007\/s10571-015-0232-4.","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"9848_CR43","doi-asserted-by":"publisher","first-page":"fcae396","DOI":"10.1093\/braincomms\/fcae396","volume":"6","author":"F Leipp","year":"2024","unstructured":"Leipp F, Vialaret J, Mohaupt P, Coppens S, Jaffuel A, Niehoff AC, et al. Glial fibrillary acidic protein in Alzheimer\u2019s disease: a narrative review. Brain Commun. 2024;6(6):fcae396. https:\/\/doi.org\/10.1093\/braincomms\/fcae396.","journal-title":"Brain Commun"},{"key":"9848_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121\u201330. https:\/\/doi.org\/10.1016\/j.ceb.2015.02.004.","journal-title":"Curr Opin Cell Biol"},{"issue":"21","key":"9848_CR45","doi-asserted-by":"publisher","first-page":"13630","DOI":"10.3390\/ijms232113630","volume":"23","author":"M Rodr\u00edguez-Giraldo","year":"2022","unstructured":"Rodr\u00edguez-Giraldo M, Gonz\u00e1lez-Reyes RE, Ram\u00edrez-Guerrero S, Bonilla-Trilleras CE, Guardo-Maya S, Nava-Mesa MO. Astrocytes as a therapeutic target in alzheimer\u2019s disease\u2013comprehensive review and recent developments. Int J Mol Sci. 2022;23(21):13630.","journal-title":"Int J Mol Sci"},{"key":"9848_CR46","doi-asserted-by":"publisher","unstructured":"Salas IH, Alfonso-Triguero M, D\u00edaz Castro B, Elazar N, Escartin C, Akl CF, et al. Astrocytes as therapeutic targets in neurodegenerative disorders. J Neurosci. 2025;45(46). https:\/\/doi.org\/10.1523\/jneurosci.1379-25.2025.","DOI":"10.1523\/jneurosci.1379-25.2025"},{"issue":"9","key":"9848_CR47","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1111\/ejn.16160","volume":"58","author":"WQ Yuan","year":"2023","unstructured":"Yuan WQ, Huang WP, Jiang YC, Xu H, Duan CS, Chen NH, et al. The function of astrocytes and their role in neurological diseases. Eur J Neurosci. 2023;58(9):3932\u201361.","journal-title":"Eur J Neurosci"},{"issue":"11","key":"9848_CR48","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3390\/cells9112415","volume":"9","author":"F Spanos","year":"2020","unstructured":"Spanos F, Liddelow SA. An overview of astrocyte responses in genetically induced Alzheimer\u2019s disease mouse models. Cells. 2020;9(11):2415.","journal-title":"Cells"},{"issue":"9","key":"9848_CR49","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cells12091309","volume":"12","author":"KY Kim","year":"2023","unstructured":"Kim KY, Shin KY, Chang K-A. GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis. Cells. 2023;12(9):1309.","journal-title":"Cells"},{"issue":"11","key":"9848_CR50","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, et al. Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain. 2021;144(11):3505\u201316.","journal-title":"Brain"},{"issue":"12","key":"9848_CR51","doi-asserted-by":"publisher","first-page":"8684","DOI":"10.1002\/alz.14318","volume":"20","author":"L G\u00f6schel","year":"2024","unstructured":"G\u00f6schel L, Dell\u2019Orco A, Fillmer A, Aydin S, Ittermann B, Riemann L, et al. Plasma p-tau181 and GFAP reflect 7T MR-derived changes in Alzheimer\u2019s disease: A longitudinal study of structural and functional MRI and MRS. Alzheimers Dement. 2024;20(12):8684\u201399. https:\/\/doi.org\/10.1002\/alz.14318.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"9848_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/ijms17030338","volume":"17","author":"YS Batarseh","year":"2016","unstructured":"Batarseh YS, Duong Q-V, Mousa YM, Al Rihani SB, Elfakhri K, Kaddoumi A. Amyloid-\u03b2 and Astrocytes Interplay in Amyloid-\u03b2 Related Disorders. Int J Mol Sci. 2016;17(3):338.","journal-title":"Int J Mol Sci"},{"key":"9848_CR53","doi-asserted-by":"publisher","unstructured":"Stanca S, Rossetti M, Bongioanni P. Astrocytes as neuroimmunocytes in Alzheimer\u2019s disease: a biochemical tool in the neuron-glia crosstalk along the pathogenetic pathways. Int J Mol Sci. 2023;24(18). https:\/\/doi.org\/10.3390\/ijms241813880.","DOI":"10.3390\/ijms241813880"},{"issue":"11","key":"9848_CR54","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1021\/acschemneuro.4c00714","volume":"16","author":"I Srivastava","year":"2025","unstructured":"Srivastava I, Goikolea J, Ayberk Kaya T, Latorre-Leal M, Eroli F, Pereira Iglesias M, et al. Reactive Astrocytes with Reduced Function of Glutamate Transporters in the App NL-GF Knock-in Mice. ACS Chem Neurosci. 2025;16(11):2035\u201347.","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"9848_CR55","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/cells11071139","volume":"11","author":"S Satarker","year":"2022","unstructured":"Satarker S, Bojja SL, Gurram PC, Mudgal J, Arora D, Nampoothiri M. Astrocytic glutamatergic transmission and its implications in neurodegenerative disorders. Cells. 2022;11(7):1139.","journal-title":"Cells"},{"key":"9848_CR56","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.arr.2021.101335","volume":"68","author":"BR Price","year":"2021","unstructured":"Price BR, Johnson LA, Norris CM. Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer\u2019s disease. Ageing Res Rev. 2021;68:101335. https:\/\/doi.org\/10.1016\/j.arr.2021.101335.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"9848_CR57","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1038\/cddis.2011.50","volume":"2","author":"C Garwood","year":"2011","unstructured":"Garwood C, Pooler A, Atherton J, Hanger D, Noble W. Astrocytes are important mediators of A\u03b2-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011;2(6):e167\u2013e.","journal-title":"Cell Death Dis"},{"issue":"1","key":"9848_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13024-025-00906-0","volume":"20","author":"X Mao","year":"2025","unstructured":"Mao X, Wang Y, Luan Y, Wang Y, Wang J, Dai W, et al. Interplay between astrocyte reactivity and APOE \u03b54 status is associated with accelerated pTau-related tau pathology in Alzheimer\u2019s disease. Mol Neurodegeneration. 2025;20(1):115.","journal-title":"Mol Neurodegeneration"},{"issue":"12","key":"9848_CR59","doi-asserted-by":"publisher","first-page":"15576","DOI":"10.1007\/s12035-025-05219-3","volume":"62","author":"EMS Bandara","year":"2025","unstructured":"Bandara EMS, Asih PR, Pedrini S, Hone E, Fernando W, Martins RN. The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer\u2019s Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression. Mol Neurobiol. 2025;62(12):15576\u2013608. https:\/\/doi.org\/10.1007\/s12035-025-05219-3.","journal-title":"Mol Neurobiol"},{"issue":"4\u20135","key":"9848_CR60","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.brainresbull.2009.07.012","volume":"80","author":"D Rossi","year":"2009","unstructured":"Rossi D, Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull. 2009;80(4\u20135):224\u201332.","journal-title":"Brain Res Bull"},{"key":"9848_CR61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuint.2019.04.005","volume":"128","author":"HL McConnell","year":"2019","unstructured":"McConnell HL, Li Z, Woltjer RL, Mishra A. Astrocyte dysfunction and neurovascular impairment in neurological disorders: Correlation or causation? Neurochem Int. 2019;128:70\u201384. https:\/\/doi.org\/10.1016\/j.neuint.2019.04.005.","journal-title":"Neurochem Int"},{"issue":"9","key":"9848_CR62","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1515\/hsz-2019-0140","volume":"400","author":"S Zulfiqar","year":"2019","unstructured":"Zulfiqar S, Garg P, Nieweg K. Contribution of astrocytes to metabolic dysfunction in the Alzheimer\u2019s disease brain. Biol Chem. 2019;400(9):1113\u201327.","journal-title":"Biol Chem"},{"key":"9848_CR63","doi-asserted-by":"publisher","first-page":"1812081","DOI":"10.3389\/fnins.2026.1812081","volume":"20","author":"J Li","year":"2026","unstructured":"Li J, Lv Z, Chen X, Fu F, Yang K, Lai G, et al. Amyloid-\u03b2 clearance: an astrocytic perspective. Front NeuroSci. 2026;20:1812081.","journal-title":"Front NeuroSci"},{"issue":"7","key":"9848_CR64","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.7150\/ijbs.109315","volume":"21","author":"X Xu","year":"2025","unstructured":"Xu X, Mei B, Yang Y, Li J, Weng J, Yang Y, et al. Astrocytes Lingering at a Crossroads: Neuroprotection and Neurodegeneration in Neurocognitive Dysfunction. Int J Biol Sci. 2025;21(7):3122\u201343. https:\/\/doi.org\/10.7150\/ijbs.109315.","journal-title":"Int J Biol Sci"},{"key":"9848_CR65","first-page":"61","volume":"11","author":"CN Winston","year":"2019","unstructured":"Winston CN, Goetzl EJ, Schwartz JB, Elahi FM, Rissman RA. Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer\u2019s disease dementia. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2019;11:61\u20136.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"issue":"1","key":"9848_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44400-025-00051-x","volume":"2","author":"JS Kim","year":"2026","unstructured":"Kim JS, Yi D, Byun MS, Ahn H, Jung G, Choi H, et al. Plasma GFAP as a mediator and moderator of A\u03b2, tau, and neurodegeneration in Alzheimer\u2019s disease. npj Dement. 2026;2(1):3.","journal-title":"npj Dement"},{"issue":"1","key":"9848_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40035-025-00515-3","volume":"14","author":"X Qi","year":"2025","unstructured":"Qi X, Zhu K, Ke W, Wang J, Mao S, Chen G. Roles of TREM2 in Alzheimer\u2019s disease. Transl Neurodegener. 2025;14(1):55. https:\/\/doi.org\/10.1186\/s40035-025-00515-3.","journal-title":"Transl Neurodegener"},{"issue":"17","key":"9848_CR68","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/cells14171387","volume":"14","author":"L Li","year":"2025","unstructured":"Li L, Zheng X, Ma H, Zhu M, Li X, Sun X, et al. TREM2 in neurodegenerative diseases: mechanisms and therapeutic potential. Cells. 2025;14(17):1387.","journal-title":"Cells"},{"key":"9848_CR69","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neurobiolaging.2018.10.022","volume":"74","author":"BS Rauchmann","year":"2019","unstructured":"Rauchmann BS, Schneider-Axmann T, Alexopoulos P, Perneczky R. CSF soluble TREM2 as a measure of immune response along the Alzheimer\u2019s disease continuum. Neurobiol Aging. 2019;74:182\u201390. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.10.022.","journal-title":"Neurobiol Aging"},{"issue":"507","key":"9848_CR70","doi-asserted-by":"publisher","first-page":"eaav6221","DOI":"10.1126\/scitranslmed.aav6221","volume":"11","author":"M Ewers","year":"2019","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med. 2019;11(507):eaav6221.","journal-title":"Sci Transl Med"},{"issue":"1","key":"9848_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Xiang X, Li Y, Bu G, Chen XF. TREM2 and sTREM2 in Alzheimer\u2019s disease: from mechanisms to therapies. Mol Neurodegener. 2025;20(1):43. https:\/\/doi.org\/10.1186\/s13024-025-00834-z.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"9848_CR72","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47(3):566\u2013e819. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008.","journal-title":"Immunity"},{"issue":"1","key":"9848_CR73","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-022-00588-y","volume":"17","author":"J Hou","year":"2022","unstructured":"Hou J, Chen Y, Grajales-Reyes G, Colonna M. TREM2 dependent and independent functions of microglia in Alzheimer\u2019s disease. Mol Neurodegener. 2022;17(1):84. https:\/\/doi.org\/10.1186\/s13024-022-00588-y.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"9848_CR74","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566\u201381. e9.","journal-title":"Immunity"},{"issue":"6","key":"9848_CR75","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","volume":"23","author":"FL Yeh","year":"2017","unstructured":"Yeh FL, Hansen DV, Sheng M. TREM2, microglia, and neurodegenerative diseases. Trends Mol Med. 2017;23(6):512\u201333.","journal-title":"Trends Mol Med"},{"key":"9848_CR76","doi-asserted-by":"publisher","unstructured":"Li L, Zheng X, Ma H, Zhu M, Li X, Sun X, et al. TREM2 in Neurodegenerative diseases: mechanisms and therapeutic potential. Cells. 2025;14(17). https:\/\/doi.org\/10.3390\/cells14171387.","DOI":"10.3390\/cells14171387"},{"issue":"6","key":"9848_CR77","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.14283\/jpad.2024.164","volume":"11","author":"M Lin","year":"2024","unstructured":"Lin M, Yu JX, Zhang WX, Lao FX, Huang H-C. Roles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer\u2019s Disease. J Prev Alzheimer\u2019s Disease. 2024;11(6):1682\u201395. https:\/\/doi.org\/10.14283\/jpad.2024.164.","journal-title":"J Prev Alzheimer\u2019s Disease"},{"issue":"1","key":"9848_CR78","doi-asserted-by":"publisher","first-page":"15318","DOI":"10.1038\/s41598-024-66211-w","volume":"14","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh F, Seyedmirzaei H, Karami S. Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer\u2019s disease: a longitudinal study. Sci Rep. 2024;14(1):15318. https:\/\/doi.org\/10.1038\/s41598-024-66211-w.","journal-title":"Sci Rep"},{"issue":"2","key":"9848_CR79","doi-asserted-by":"publisher","first-page":"e16987","DOI":"10.15252\/emmm.202216987","volume":"15","author":"D Biel","year":"2023","unstructured":"Biel D, Su\u00e1rez-Calvet M, Hager P, Rubinski A, Dewenter A, Steward A, et al. sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer\u2019s disease. EMBO Mol Med. 2023;15(2):e16987. https:\/\/doi.org\/10.15252\/emmm.202216987.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"9848_CR80","doi-asserted-by":"publisher","first-page":"e183597","DOI":"10.1001\/jamanetworkopen.2018.3597","volume":"1","author":"Q Tao","year":"2018","unstructured":"Tao Q, Ang TFA, DeCarli C, Auerbach SH, Devine S, Stein TD, et al. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers. JAMA Netw Open. 2018;1(6):e183597\u2013e. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3597.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"9848_CR81","doi-asserted-by":"publisher","first-page":"e183597","DOI":"10.1001\/jamanetworkopen.2018.3597","volume":"1","author":"Q Tao","year":"2018","unstructured":"Tao Q, Ang TFA, DeCarli C, Auerbach SH, Devine S, Stein TD, et al. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers. JAMA Netw Open. 2018;1(6):e183597. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3597.","journal-title":"JAMA Netw Open"},{"key":"9848_CR82","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","volume":"9","author":"S Yang","year":"2018","unstructured":"Yang S, Wang J, Brand DD, Zheng SG. Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications. Front Immunol. 2018;9:784. https:\/\/doi.org\/10.3389\/fimmu.2018.00784.","journal-title":"Front Immunol"},{"issue":"1","key":"9848_CR83","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12974-021-02200-4","volume":"18","author":"I Papazian","year":"2021","unstructured":"Papazian I, Tsoukala E, Boutou A, Karamita M, Kambas K, Iliopoulou L, et al. Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKK\u03b2 promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice. J Neuroinflamm. 2021;18(1):222.","journal-title":"J Neuroinflamm"},{"issue":"11","key":"9848_CR84","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.10.012","volume":"31","author":"P Buchhave","year":"2010","unstructured":"Buchhave P, Zetterberg H, Blennow K, Minthon L, Janciauskiene S, Hansson O. Soluble TNF receptors are associated with A\u03b2 metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiol Aging. 2010;31(11):1877\u201384. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.10.012.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"9848_CR85","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/antib4040369","volume":"4","author":"Y Dong","year":"2015","unstructured":"Dong Y, Dekens DW, De Deyn PP, Naud\u00e9 PJW, Eisel ULM. Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders. Antibodies. 2015;4(4):369\u2013408.","journal-title":"Antibodies"},{"key":"9848_CR86","doi-asserted-by":"publisher","unstructured":"Ort\u00ed-Casa\u00f1 N, Wu Y, Naud\u00e9 PJW, De Deyn PP, Zuhorn IS, Eisel ULM. Targeting TNFR2 as a novel therapeutic strategy for Alzheimer\u2019s disease. Front NeuroSci. 2019;13. https:\/\/doi.org\/10.3389\/fnins.2019.00049.","DOI":"10.3389\/fnins.2019.00049"},{"issue":"20","key":"9848_CR87","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.2174\/138161209788682398","volume":"15","author":"J Arribas","year":"2009","unstructured":"Arribas J, Esselens C. ADAM17 as a therapeutic target in multiple diseases. Curr Pharm Design. 2009;15(20):2319\u201335.","journal-title":"Curr Pharm Design"},{"key":"9848_CR88","doi-asserted-by":"publisher","first-page":"1640090","DOI":"10.3389\/fphar.2025.1640090","volume":"16","author":"L Liu","year":"2025","unstructured":"Liu L, Tian E, Quan S, Su C, Zhou J, Hu S, et al. ADAM17 as a promising therapeutic target: from structural basis to inhibitor discovery in human diseases. Front Pharmacol. 2025;16:1640090. https:\/\/doi.org\/10.3389\/fphar.2025.1640090.","journal-title":"Front Pharmacol"},{"issue":"1","key":"9848_CR89","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13195-021-00943-z","volume":"13","author":"L-Z Ma","year":"2021","unstructured":"Ma L-Z, Hu H, Wang Z-T, Ou Y-N, Dong Q, Tan L, et al. P-tau and neurodegeneration mediate the effect of \u03b2-amyloid on cognition in non-demented elders. Alzheimers Res Ther. 2021;13(1):200. https:\/\/doi.org\/10.1186\/s13195-021-00943-z.","journal-title":"Alzheimers Res Ther"},{"key":"9848_CR90","doi-asserted-by":"publisher","first-page":"175628642513147","DOI":"10.1177\/17562864251314773","volume":"18","author":"D Plantone","year":"2025","unstructured":"Plantone D, Pardini M, Manco C, Righi D, Al\u00ec PA, Arnaldi D, et al. CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study. Ther Adv Neurol Disord. 2025;18:17562864251314773. https:\/\/doi.org\/10.1177\/17562864251314773.","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"9848_CR91","doi-asserted-by":"publisher","first-page":"e70293","DOI":"10.1002\/dad2.70293","volume":"18","author":"H Wei","year":"2026","unstructured":"Wei H, Zhang C, Wen P, Kong M, Ba M. Plasma glial fibrillary acidic protein as a mediator of amyloid-associated cognitive decline over 4-year follow-up in pre-dementia stages. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2026;18(1):e70293. https:\/\/doi.org\/10.1002\/dad2.70293.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"issue":"1","key":"9848_CR92","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/alz.13450","volume":"20","author":"W Pelkmans","year":"2024","unstructured":"Pelkmans W, Shekari M, Brugulat-Serrat A, S\u00e1nchez-Benavides G, Minguill\u00f3n C, Fauria K, et al. Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer\u2019s disease progression. Alzheimer\u2019s Dement. 2024;20(1):483\u201393. https:\/\/doi.org\/10.1002\/alz.13450.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"9848_CR93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","volume":"4","author":"LF Eng","year":"1994","unstructured":"Eng LF, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol. 1994;4(3):229\u201337.","journal-title":"Brain Pathol"},{"key":"9848_CR94","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018;9:754. https:\/\/doi.org\/10.3389\/fimmu.2018.00754.","journal-title":"Front Immunol"},{"key":"9848_CR95","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2019.00049","volume":"13","author":"N Ort\u00ed-Casa\u00f1","year":"2019","unstructured":"Ort\u00ed-Casa\u00f1 N, Wu Y, Naud\u00e9 PJW, De Deyn PP, Zuhorn IS, Eisel ULM. Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer\u2019s Disease. Front Neurosci. 2019;13:49. https:\/\/doi.org\/10.3389\/fnins.2019.00049.","journal-title":"Front Neurosci"},{"issue":"9","key":"9848_CR96","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.tjpad.2026.100644","volume":"13","author":"KY Kim","year":"2026","unstructured":"Kim KY, Ham H, Yoon EJ, Kim E, Kim YK, Lee J-Y. Relative importance of blood-based biomarkers for Alzheimer\u2019s disease-specific neurodegeneration and cognitive decline. J Prev Alzheimer\u2019s Disease. 2026;13(9):100644. https:\/\/doi.org\/10.1016\/j.tjpad.2026.100644.","journal-title":"J Prev Alzheimer\u2019s Disease"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09848-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:04:28Z","timestamp":1790348668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09848-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9848"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09848-1","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted using ADNI data. The ADNIstudy is ethically approved and operated in accordance with the Declaration of Helsinki, 1964.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"114"}}